title: [Determination of beta 2 microglobulin in malignant tumors of the ovaries].
abstract: Beta 2-microglobulin (beta 2-MG) is used as a tumour marker in some malignant diseases. The authors assessed the concentration of beta 2-MG in serum of 30 patients with malignant ovarian tumours and in 29 patients with other benign gynaecological diseases, in particular benign ovarian tumours. Although raised values of beta 2-MG were found in ovarian carcinomas, as compared with the control group of non-malignant gynaecological diseases, a statistically significant increase was recorded only in carcinomas grade III and IV.
authors.forename: M
authors.initials: M
authors.lastname: Kudela
authors.forename: E
authors.initials: E
authors.lastname: Fischerová
authors.forename: L
authors.initials: L
authors.lastname: Hansmanová
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D001613:beta 2-Microglobulin / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D001613:beta 2-Microglobulin
vernacular_title: Stanovení beta 2 mikroglobulinu (beta 2-MG) u maligních nádorů ovarií.